share_log

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9

Benzinga ·  Aug 2, 2023 18:23

HC Wainwright & Co. analyst Robert Burns maintains Portage Biotech (NASDAQ:PRTG) with a Buy and lowers the price target from $21 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment